Meningococcal vaccine group B OMV - Intravacc
Alternative Names: Avacc 13; Nonamen®; OMV-based meningococcal group B vaccine - IntravaccLatest Information Update: 26 Mar 2024
At a glance
- Originator Intravacc
- Class Meningococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Meningococcal group B infections
Most Recent Events
- 27 Feb 2024 Preclinical trials in Meningococcal group B infections (Prevention) in Netherlands (IM), prior to February 2024 (Intravacc pipeline, February 2024)
- 27 Feb 2024 Pharmacodynamics and adverse event data from a preclinical trial in Meningococcal group B infections released by Intravacc (Intravacc pipeline, February 2024)